These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1859487)

  • 1. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.
    Petri M; Genovese M; Engle E; Hochberg M
    Arthritis Rheum; 1991 Aug; 34(8):937-44. PubMed ID: 1859487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience.
    Petri M; Howard D; Repke J
    Arthritis Rheum; 1991 Dec; 34(12):1538-45. PubMed ID: 1670196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flares in pediatric systemic lupus erythematosus.
    Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
    J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus.
    Katz P; Wan GJ; Daly P; Topf L; Connolly-Strong E; Bostic R; Reed ML
    Qual Life Res; 2020 Dec; 29(12):3251-3261. PubMed ID: 32683643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
    Thanou A; Chakravarty E; James JA; Merrill JT
    Rheumatology (Oxford); 2014 Dec; 53(12):2175-81. PubMed ID: 24729400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
    Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.
    Rogers JL; Clowse MEB; McKenna K; Starling S; Swezey T; Molokwu N; Corneli A; Pisetsky DS; Sun K; Criscione-Schreiber LG; Sadun RE; Maheswaranathan M; Burshell D; Doss J; Eudy AM
    J Rheumatol; 2024 May; 51(5):488-494. PubMed ID: 38101916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies.
    Ruiz-Irastorza G; Lima F; Alves J; Khamashta MA; Simpson J; Hughes GR; Buchanan NM
    Br J Rheumatol; 1996 Feb; 35(2):133-8. PubMed ID: 8612024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for lupus flares in sub-Saharan Africa-retrospective cross-sectional study.
    Legesse BA; Adugna BA; Ayalew ZS; Azibte GT; Abdulkadir SI; Mengist BA; Zewde DA; Kassa AZ; Abera BM; Gudetta AB
    Clin Rheumatol; 2024 Sep; 43(9):2867-2875. PubMed ID: 39090484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Activity and Rate and Severity of Flares During Peripartum Period in Thai Patients With Systemic Lupus Erythematosus: An Age at Diagnosis and Disease Duration Matched Controlled Study.
    Louthrenoo W; Trongkamolthum T; Kasitanon N; Wongthanee A
    J Clin Rheumatol; 2022 Mar; 28(2):e473-e479. PubMed ID: 34176885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study.
    Petri M; Singh S; Tesfasyone H; Malik A
    J Rheumatol; 2009 Nov; 36(11):2476-80. PubMed ID: 19833757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
    Laustrup H; Voss A; Green A; Junker P
    Lupus; 2010 Mar; 19(3):239-46. PubMed ID: 19946037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
    Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
    Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view.
    Ehrenstein MR; Conroy SE; Heath J; Latchman DS; Isenberg DA
    Br J Rheumatol; 1995 Mar; 34(3):257-60. PubMed ID: 7728402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.
    Nikpour M; Urowitz MB; Ibañez D; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1152-8. PubMed ID: 19714602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.
    Eudy AM; Siega-Riz AM; Engel SM; Franceschini N; Howard AG; Clowse MEB; Petri M
    Ann Rheum Dis; 2018 Jun; 77(6):855-860. PubMed ID: 29463519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus.
    Brunner HI; Holland M; Beresford MW; Ardoin SP; Appenzeller S; Silva CA; Flores F; Goilav B; Wenderfer SE; Levy DM; Ravelli A; Khunchandani R; Avcin T; Klein-Gitelman MS; Feldman BM; Ruperto N; Ying J;
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):813-822. PubMed ID: 29693328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.